[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Baksi et al., 1986 - Google Patents

Effect of in vivo antiestrogen pretreatment on rabbit atrial chronotropic response to histamine

Baksi et al., 1986

Document ID
8838447034023460710
Author
Baksi S
Hughes M
Publication year
Publication venue
Agents and Actions

External Links

Snippet

The chronotropic response (Δ rate) to histamine (1.4 to 1.8× 10− 6 M) of isolated atria from antiestrogen (tamoxifen)-pretreated immature female rabbit was investigated. Tamoxifen treatment (1.0 and 10.0 mg/kg/day for 14 days) had no significant effect on the Δ rate. The R …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00—Drug, bio-affecting and body treating compositions
    • Y10S514/899—Menstrual disorder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Advis et al. Activation of growth hormone short loop negative feedback delays puberty in the female rat
Döhler et al. Differentiation of the sexually dimorphic nucleus in the preoptic area of the rat brain is inhibited by postnatal treatment with an estrogen antagonist
WHITSETT et al. β-Adrenergic receptors and catecholamine-sensitive adenylate cyclase of the human placenta
Armstead Opioids and nitric oxide contribute to hypoxia-induced pial arterial vasodilation in newborn pigs
Ishimaru et al. Altered metabolism of androgens in elderly men with benign prostatic hyperplasia
Meites Relation of the neuroendocrine system to the development and growth of experimental mammary tumors
Holland Gonadotropin-Lndependent Precocious Puberty
Silvia et al. Cellular and molecular mechanisms involved in luteolysis and maternal recognition of pregnancy in the ewe
Gluckman et al. Hormone ontogeny in the ovine fetus: XIV. The effect of 17β-estradiol infusion on fetal plasma gonadotropins and prolactin and the maturation of sex steroid-dependent negative feedback
Linde‐Forsberg et al. Termination of mid‐term pregnancy in the dog with oral RU 486
Eaton et al. Self-injurious behavior is decreased by cyproterone acetate in adult male rhesus (Macaca mulatta)
JP2002508322A (en) Use of aromatase inhibitors in treating low androgen to estrogen ratios and detrusor-sphincter ataxia in men, and methods of testing impaired coordination in male rodents
Li et al. Stimulation of prolactin secretion in the pig: central effects of relaxin and the antiprogesterone RU 486
Wilkinson et al. Gonadal steroid modification of adrenergic and opiate receptor binding in the central nervous system
JPH09328421A (en) Use of (e)-1-(4'-(2-alkylaminoethoxy)phenyl)-1-(3'-hydroxyphenyl)-2-phenylbut-1-ene in order to suppress morbid state
Kelly et al. High inhibitory activity of a new antiestrogen, RU 16117 (11α-methoxy ethinyl estradiol), on the development of dimethylbenz (a) anthracene-induced mammary tumors
Baksi et al. Effect of in vivo antiestrogen pretreatment on rabbit atrial chronotropic response to histamine
Kwa et al. An overall perspective on the role of prolactin in the breast
Williams et al. Treatment of adrenal insufficiency
Engstrom et al. Desensitization of beta~ 2-adrenoceptor function in non-pregnant rat myometrium is modulated by sex steroids
Aguado et al. Effect of selective removal of the adrenal medulla on female sexual development
KR20040012751A (en) Aromatase inhibition to enhance assisted reproduction
Wolff Hereditary obesity and hormone deficiencies in yellow dwarf mice
Fuchs et al. Prostaglandin F2α regulation of LH-stimulated testosterone production in rat testis
US4657932A (en) Method of treating prolactin-related disorders